glp 1 for nash Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Multiple target tissue effects of

H., Hoffmann K., Allen N., et al., Body Size and Breast Cancer Risk: Findings From the European Prospective Investigation Into Cancer and Nutrition (EPIC), International Journal of Cancer 111 (2004): 762771

Diabetes Res

Interestingly, obesity, for whose treatment GLP-1RAs are approved and validated 1,214 , is not classified under mental and behavioral disorders, and in some countries, such as the United Kingdom, it is not even formally recognized as a disease 246

A list of software used is available in the Methods section and Reporting Summary

And what it might mean for the millions of people searching for better options than what conventional treatment currently offers

In particular, the administration of empagliflozin in individuals with prediabetes or diabetes was associated with the amelioration of glycemia and insulin sensitivity and with increased -hydroxybutyrate (BHB) levels